Fillmore gains edge in fight for Genesis
The San Francisco firm’s offer of $69.25 per share has been deemed “superior” by the board of Genesis Health Care—though there is still time for a counter-offer from JER and Formation.
The San Francisco firm’s offer of $69.25 per share has been deemed “superior” by the board of Genesis Health Care—though there is still time for a counter-offer from JER and Formation.
Copyright PEI Media
Not for publication, email or dissemination
